STOCK TITAN

NeoVolta Inc. (NEOV) Financials

NEOV
FY2026 annual
Revenue $13.3M +58.2% YoY
Net Income -$21.5M -326.5% YoY
EPS (Diluted) -$0.55 -266.7% YoY
Operating Cash Flow -$15.2M -243.3% YoY
Market Cap $180.0M as of Oct 3, 2026
Price / Sales 13.5x on $13.3M revenue, FY2026
Price / Earnings n/m net loss, so no earnings multiple, FY2026
Price / Book 4.5x on $39.6M equity, Q4 FY2026

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 3, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period FY2026, ended Jun 30, 2026 Reported Currency USD FYE June

Newest figures come from the 10-K for FY2026, filed Sep 23, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the NEOV SEC filings page.

NeoVolta Inc. (NEOV) reported $13.3M in revenue for fiscal year 2026, up 58.2% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 6 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI NEOV FY2026

Revenue expanded sharply, but FY2026’s larger scale was overwhelmed by operating costs, losses, and new financing.

The business converted higher sales into weaker economics: revenue rose from $8.4M to $13.3M, while gross margin narrowed from 17.9% to 16.0% and operating expenses pushed the operating loss to $18.1M. Because operating cash outflow was $15.2M against a net loss of $21.5M, reported earnings included substantial non-cash or timing effects rather than matching cash consumption exactly.

Scale did not yet produce operating leverage: selling, general and administrative expense reached $18.3M in FY2026, exceeding gross profit of $2.1M. The resulting operating margin of -136.1% was materially worse than FY2025’s -56.0% despite stronger revenue.

The balance sheet expanded through financing rather than operations: financing cash inflow was $48.4M while operating and investing cash outflows totaled $23.8M. Current ratio improved to 4.9x, and reported liquidity equaled 17.5 months of the latest annual operating outflow, but shares outstanding also rose from 34.2M to 59.0M.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Cash Runway Dilution R&DIntensity Revenue Progress BurnTrend BalanceSheet 42 / 100
Financial Health Score 42/100
Scored as: Emerging companies peer group

Scored against emerging companies for FY2026. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of NeoVolta Inc.'s business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Cash Runway
42

NeoVolta Inc. held $22.2M in cash, cash equivalents and investments at the end of fiscal year 2026, and its operations used $15.2M of cash that year. Cash Runway ranks emerging companies on the size of that balance against the outflow behind it, and NeoVolta Inc. scores 42/100 among other emerging companies.

Dilution
25

NeoVolta Inc. had 59M shares outstanding at the end of fiscal year 2026, against 34M in fiscal year 2025. Dilution ranks emerging companies on how fast that count has grown over three years, where a slower rise is the better one, and NeoVolta Inc. scores 25/100 among other emerging companies.

R&D Intensity
24

NeoVolta Inc. spent $1.6M on research and development in fiscal year 2026, which was 4.9% of its operating costs that year. R&D Intensity ranks emerging companies on the share of operating costs that goes into research, and NeoVolta Inc. scores 24/100 among other emerging companies.

Revenue Progress
88

NeoVolta Inc. reported revenue of $13.3M in fiscal year 2026, against $8.4M in fiscal year 2025. Revenue Progress ranks emerging companies on the three-year path of that line, and NeoVolta Inc. scores 88/100 among other emerging companies.

Burn Trend
1

NeoVolta Inc.'s operations used $15.2M of cash in fiscal year 2026, against $4.4M used in fiscal year 2025. Burn Trend ranks emerging companies on which way that figure has moved over three years, and NeoVolta Inc. scores 1/100 among other emerging companies.

Balance Sheet
70

NeoVolta Inc.'s cash, cash equivalents and investments came to $22.2M at the end of fiscal year 2026, against $14.1M of total liabilities. Balance Sheet ranks emerging companies on that comparison, and NeoVolta Inc. scores 70/100 among other emerging companies.

Altman Z-Score Safe
6.16

NeoVolta Inc. scores 6.16, well above the 2.99 safe threshold. The score is driven primarily by a large market capitalization ($180.0M) relative to total liabilities ($14.1M). This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Partial
3/8

NeoVolta Inc. passes 3 of 8 computable financial strength tests (1 of the nine could not be computed from available data). 2 of 4 profitability signals pass, 1 of 2 leverage/liquidity signals pass, neither operating efficiency signal passes.

Earnings Quality No Cash Backing
N/A

NeoVolta Inc. reported a net loss of $21.5M while operations used $15.2M of cash. With neither figure positive, the ratio between the two carries no quality signal.

Interest Coverage At Risk
N/A

NeoVolta Inc. reported an operating loss of $18.1M against $668K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$13K
YoY-99.7%
QoQ-99.3%

NeoVolta Inc. generated $13K in revenue in Q4 2026. This represents a decrease of 99.7% from the same quarter a year earlier. Against the prior quarter it is down 99.3%.

Net Income
-$11.7M
YoY-606.8%
QoQ-285.0%

NeoVolta Inc. reported -$11.7M in net income in Q4 2026. This represents a decrease of 606.8% from the same quarter a year earlier. Against the prior quarter it is down 285.0%.

EPS (Diluted)
-$0.28
YoY-460.0%
QoQ-250.0%

NeoVolta Inc. earned -$0.28 per diluted share (EPS) in Q4 2026. This represents a decrease of 460.0% from the same quarter a year earlier. Against the prior quarter it is down 250.0%.

EBITDA

Not reported for Q4 2026.

Cash & Balance Sheet

Cash & Debt
$22.2M
YoY+2693.3%
QoQ+93.4%
5Y CAGR+120.5%

NeoVolta Inc. held $22.2M in cash as of Q4 2026; long-term debt is not reported for that period.

Shares Outstanding
59M
YoY+72.5%
QoQ+38.2%

NeoVolta Inc. had 59M shares outstanding in Q4 2026. This represents an increase of 72.5% from the same quarter a year earlier. Against the prior quarter it is up 38.2%.

Free Cash Flow

Not reported for Q4 2026.

Dividends Per Share

Not reported for Q4 2026.

Margins & Returns

Return on Equity
-29.5%
YoY+27.2pp
QoQ-15.8pp

NeoVolta Inc.'s ROE was -29.5% in Q4 2026, measuring profit generated per dollar of shareholder equity. This is up 27.2 percentage points from the same quarter a year earlier. Against the prior quarter it is down 15.8 percentage points.

Gross Margin

Not shown for Q4 2026: the reported ratio is below -100.0% of revenue, so it does not read as a share of revenue.

Operating Margin

Not shown for Q4 2026: the reported ratio is below -100.0% of revenue, so it does not read as a share of revenue.

Net Margin

Not shown for Q4 2026: the reported ratio is below -100.0% of revenue, so it does not read as a share of revenue.

Capital Allocation

R&D Spending
$1.0M
YoY+1221.7%
QoQ+156.6%

NeoVolta Inc. invested $1.0M in research and development in Q4 2026. This represents an increase of 1221.7% from the same quarter a year earlier. Against the prior quarter it is up 156.6%.

Share Buybacks

Not reported for Q4 2026.

Capital Expenditures

Not reported for Q4 2026.

NEOV Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

NEOV quarterly income statement
MetricQ4'2610-KQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-KQ3'2510-QQ2'2510-QQ1'2510-Q
Revenue$13K-99.7%$2.0M+0.5%$4.6M+333.5%$6.7M+1026.7%$4.8M+720.2%$2.0M+609.4%$1.1M+5.3%$590K-22.8%
Cost of Revenue$1.2M-72.4%$1.1M-26.9%$3.9M+418.0%$5.1M+919.9%$4.2M+642.9%$1.5M+1173.5%$748K-7.9%$497K-22.6%
Gross Profit-$1.1M-298.0%$928K+80.3%$773K+138.5%$1.6M+1598.8%$575K+3254.0%$515K+209.7%$324K+57.3%$93K-23.4%
R&D Expenses$1.0M+1221.7%$404K+1345.2%$59K+38.9%$57K+560.5%$78K+795.0%$28K+168.9%$42K$9K
SG&A Expenses$7.9M+307.9%$3.0M+62.6%$5.1M+313.7%$2.4M+126.1%$1.9M+160.0%$1.9M+145.7%$1.2M+58.6%$1.1M+89.2%
Operating Income-$10.2M-611.1%-$2.6M-91.5%-$4.5M-372.7%-$854K+11.6%-$1.4M-95.2%-$1.4M-128.4%-$947K-66.5%-$966K-122.6%
EBITDAN/A-$2.5M-82.1%-$4.4M-361.3%N/AN/A-$1.4M-$947KN/A
Interest Expense$616K+153.0%$52K-34.0%-$425-25.4%-$140+90.0%$244K$78K-$339-$1K
Net Income-$11.7M-606.8%-$3.0M-109.0%-$5.5M-470.3%-$1.2M-28.9%-$1.6M-126.3%-$1.4M-145.9%-$971K-74.7%-$964K-125.0%
EPS (Basic)-$0.28-460.0%-$0.08-100.0%-$0.16-433.3%-$0.04-33.3%-$0.05-150.0%-$0.04-100.0%-$0.03-50.0%-$0.03-200.0%
EPS (Diluted)-$0.28-460.0%-$0.08-100.0%-$0.16-433.3%-$0.04-33.3%-$0.05-150.0%-$0.04-100.0%-$0.03-50.0%-$0.03-200.0%
Diluted Shares (Avg)N/A40M+20.0%35M+5.1%34M+2.9%N/A33M+0.8%33M+0.2%33M+0.3%

Not reported in any period shown, so not listed: Income Tax.

NEOV Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

NEOV quarterly balance sheet
MetricQ4'2610-KQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-KQ3'2510-QQ2'2510-QQ1'2510-Q
Total Assets$53.6M+688.2%$25.7M+349.3%$10.1M+151.7%$8.4M+103.5%$6.8M+46.1%$5.7M+10.8%$4.0M-29.2%$4.2M-32.8%
Current Assets$32.8M+392.9%$22.2M+289.2%$7.8M+93.7%$8.4M+101.4%$6.7M+43.1%$5.7M+10.8%$4.0M-29.2%$4.2M-32.8%
Cash & Equivalents$22.2M+2693.3%$11.5M+2042.1%$242K-26.3%$890K+126.2%$795K-19.4%$536K-47.1%$329K-78.1%$393K-78.4%
Short-Term Investments$0$0$0$0$0$0$0$0
Inventory$2.1M-0.2%$2.2M-3.8%$1.9M-8.7%$1.5M-16.3%$2.1M+19.6%$2.3M+6.7%$2.0M+2.6%$1.8M-20.6%
Accounts Receivable$2.9M-1.3%$6.1M+160.2%$5.3M+220.6%$5.2M+167.1%$3.0M+65.2%$2.4M+24.9%$1.7M-24.2%$2.0M-6.0%
Long-Term Investments$0$0$0$0$0$0$0$0
Total Liabilities$14.1M+261.2%$3.5M+84.8%$5.1M+612.0%$6.3M+2388.0%$3.9M+6275.5%$1.9M+12425.7%$718K+5999.3%$254K+414.0%
Current Liabilities$6.7M+90.2%$2.7M+82.8%$3.7M+1009.2%$5.7M+2138.3%$3.5M+5647.8%$1.5M+9877.4%$334K+2740.4%$254K+414.0%
Non-Current Liabilities$7.4M+1827.4%$738K+92.5%$1.4M+265.7%$634K$384K$384K$384K$0
Total Equity$39.6M+1259.8%$22.2M+479.7%$5.0M+51.6%$2.1M-45.3%$2.9M-36.7%$3.8M-25.5%$3.3M-41.7%$3.9M-36.4%
Retained Earnings-$47.2M-83.3%-$35.6M-47.5%-$32.6M-43.6%-$27.0M-24.5%-$25.8M-24.3%-$24.1M-20.6%-$22.7M-16.8%-$21.7M-15.0%

Not reported in any period shown, so not listed: Goodwill, Long-Term Debt.

NEOV Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

NEOV quarterly cash flow statement
MetricQ4'2610-KQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-KQ3'2510-QQ2'2510-QQ1'2510-Q
Operating Cash Flow-$7.0M-661.1%-$3.6M-74.6%-$2.1M-142.8%-$2.5M-320.6%-$924K-3256.6%-$2.1M-322.4%-$858K-164.6%-$593K-231.1%
Depreciation & AmortizationN/A$128K$108KN/AN/A$0$0N/A
Stock-Based CompensationN/AN/AN/A$467K+75.9%N/AN/AN/A$265K+213.3%
Investing Cash Flow-$5.8M-$2.3MN/AN/A$0$0N/AN/A
Financing Cash Flow$26.8M+2161.1%$17.1M+657.6%$1.9M+144.0%$2.6M$1.2M$2.3M$794K$0

Not reported in any period shown, so not listed: Capital Expenditures, Free Cash Flow, Dividends Paid, Share Buybacks.

NEOV Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

NEOV quarterly financial ratios
MetricQ4'2610-KQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-KQ3'2510-QQ2'2510-QQ1'2510-Q
Gross Margin-8465.1%45.9%+20.3pp16.6%-13.6pp23.7%+8.0pp12.1%+9.2pp25.6%-33.0pp30.2%+10.0pp15.7%-0.1pp
Operating Margin-75670.3%-129.7%-96.4%-8.0pp-12.8%-30.1%-68.1%-88.4%-32.5pp-163.6%
Net Margin-86628.4%-149.7%-119.2%-18.7%-34.7%-72.0%-90.6%-36.0pp-163.4%
Return on Equity-29.5%+27.2pp-13.7%+24.2pp-110.7%-81.3pp-58.3%-33.5pp-56.7%-40.8pp-37.9%-26.4pp-29.4%-19.6pp-24.8%-17.8pp
Return on Assets-21.7%+2.5pp-11.8%+13.6pp-54.8%-30.6pp-14.7%+8.5pp-24.2%-8.6pp-25.4%-13.9pp-24.2%-14.4pp-23.2%-16.3pp
Current Ratio4.92+3.0x8.10+4.3x2.10-9.9x1.47-14.9x1.90-74.3x3.80-338.5x12.02-470.2x16.35-108.6x
Debt-to-Equity0.36-1.0x0.16-0.3x1.02+0.8x2.96+2.9x1.34+1.3x0.49+0.5x0.22+0.2x0.07+0.1x
Asset Turnover0.00-0.7x0.08-0.3x0.46+0.2x0.79+0.6x0.70+0.6x0.35+0.3x0.27+0.1x0.140.0x

Not reported in any period shown, so not listed: FCF Margin.

Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: Gross Margin, Operating Margin, Net Margin.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company Fiscal year Revenue Net income Net margin Market cap Health score
NeoVolta Inc. NEOV FY2026 $13.3M -$21.5M N/A $180.0M 42/100
Tecogen Inc. TGEN FY2025 $27.1M -$8.2M -30.5% $80.0M 35/100
Espey Mfg. & Electronics Corp ESP FY2026 $46.1M $11.2M 24.2% $181.4M 72/100
FuelCell Energy Inc NEW (DE) FCEL FY2025 $158.2M -$187.9M N/A $1.5B 60/100
NOVONIX Limited NVX FY2025 $5.6M -$92.7M N/A $65.6M 15/100
Electrovaya Inc. ELVA FY2025 N/A N/A N/A $328.2M —

Frequently Asked Questions

What is NeoVolta Inc.'s annual revenue?

NeoVolta Inc. (NEOV) reported $13.3M in total revenue for fiscal year 2026. This represents a 58.2% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is NeoVolta Inc.'s revenue growing?

NeoVolta Inc. (NEOV) revenue grew by 58.2% year-over-year, from $8.4M to $13.3M in fiscal year 2026.

Is NeoVolta Inc. profitable?

No, NeoVolta Inc. (NEOV) reported a net income of -$21.5M in fiscal year 2026.

NeoVolta Inc. (NEOV) reported diluted earnings per share of -$0.55 for fiscal year 2026. This represents a -266.7% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

NeoVolta Inc. (NEOV) had EBITDA of -$17.7M in fiscal year 2026, measuring earnings before interest, taxes, depreciation, and amortization.

NeoVolta Inc. (NEOV) had a gross margin of 16.0% in fiscal year 2026, indicating the percentage of revenue retained after direct costs of goods sold.

NeoVolta Inc. (NEOV) has a return on equity of -54.3% for fiscal year 2026, measuring how efficiently the company generates profit from shareholder equity.

NeoVolta Inc. (NEOV) recorded an outflow of $15.2M in operating cash flow during fiscal year 2026, representing cash used by core business activities.

NeoVolta Inc. (NEOV) had $53.6M in total assets as of fiscal year 2026, including both current and long-term assets.

NeoVolta Inc. (NEOV) invested $1.6M in research and development during fiscal year 2026.

NeoVolta Inc. (NEOV) had 59M shares outstanding as of fiscal year 2026.

NeoVolta Inc. (NEOV) had a current ratio of 4.92 as of fiscal year 2026, which is generally considered healthy.

NeoVolta Inc. (NEOV) had a debt-to-equity ratio of 0.36 as of fiscal year 2026, measuring the company's financial leverage by comparing total debt to shareholder equity.

NeoVolta Inc. (NEOV) had a return on assets of -40.0% for fiscal year 2026, measuring how efficiently the company uses its assets to generate profit.

NeoVolta Inc. (NEOV) has no price-to-earnings ratio at the moment: net loss, so no earnings multiple (FY2026). The market capitalization is $180.0M as of Oct 3, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

NeoVolta Inc. (NEOV) trades at 13.5x sales, its market capitalization divided by revenue of $13.3M revenue, FY2026. The market capitalization is $180.0M as of Oct 3, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

At the end of fiscal year 2026, NeoVolta Inc. (NEOV) held $22.2M in cash, cash equivalents and investments, and reported an operating cash outflow of $15.2M over that year. Dividing the one by the other, the reported balance equals about 18 months of the outflow reported that year. This is arithmetic over figures already filed, not a projection: it assumes nothing about future spending, financing or operations.

NeoVolta Inc. (NEOV) has an Altman Z-Score of 6.16, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

NeoVolta Inc. (NEOV) has a Piotroski F-Score of 3 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

NeoVolta Inc. (NEOV) reported a net loss of $21.5M while operations used $15.2M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

NeoVolta Inc. (NEOV) reported an operating loss of $18.1M against $668K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

NeoVolta Inc. (NEOV) scores 42 out of 100 on our Financial Health Score, indicating moderate standing within its emerging companies peer group. The score is a 0-100 composite of six dimensions (Cash Runway, Dilution, R&D Intensity, Revenue Progress, Burn Trend, Balance Sheet), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.

Back to top